Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Chua, Siew Siang ^a   Kok, Li Ching ^b   Md Yusof, Faridah Aryani ^b   Tang, Guang Hui ^b   Lee, Shaun Wen Huey ^c   Efendie, Benny ^c,d   Paraidathathu, Thomas ^e  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

^c SEGI UNIVERSITY   (Malaysia)

^d INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^e UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Chronic disease; Drug related problem; Intervention; Pharmaceutical care; Pharmacist

Indexed keywords

ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG THERAPY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALAYSIA; MALE; METHODOLOGY; MIDDLE AGED; PATIENT CARE; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD;

DIABETES MELLITUS; DRUG THERAPY; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALAYSIA; MALE; MIDDLE AGED; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE;

EID: 84868632493     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-388     Document Type: Article

References (29)

1. Opportunities and responsibilities in pharmaceutical care. Hepler C, Strand L, Am J Hosp Pharm 1990 47 533 543 2316538 (Pubitemid 20138134)
2. Drug-related problems: a cornerstone for pharmaceutical care. van Mil F, J Malta College Pharm Pract 2005 10 5 8
3. Pharmaceutical Care Network Europe (PCNE) Foundation, PCNE classification for drug related problems (revised 01-05-06 vm) V5.01; 2006 http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V5.01.pdf
4. A classification system for issues identified in pharmaceutical care practice. Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. Int J Pharm Pract 2002 10 91 100 10.1111/j.2042-7174.2002.tb00593.x (Pubitemid 34733344)
5. Drug-related morbidity and mortality: updating the cost-of-illness model. Ernst FR, Grizzle AJ, J Am Pharm Assoc 2001 41: 192 199
6. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team: a pilot study. Wermeille J, Bennie M, Brown I, McKnight J, Pharm World Sc 2004 26 18 25 (Pubitemid 38250176)
7. The role of pharmaceutical care in diabetes management. Davis TM, Clifford RM, Davis WA, Batty KT, Brit J Diabet Vasc Dis 2005 5 352 356 10.1177/14746514050050061001 (Pubitemid 43078634)
8. The Pharmaceutical care of patients with type 2 diabetes mellitus. Borges A, Guidoni C, Ferreira L, Freitas OD, Pereira L, Pharm World Sc 2010 32 6 730 736 10.1007/s11096-010-9428-3
9. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Jameson JP, Baty PJ, Am J Manag Care 2010 16 4 250 255 20394460
10. Pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. Diabet Med 2007 24 677 683 10.1111/j.1464-5491. 2007.02143.x 17523968 (Pubitemid 46808869)
11. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. J Clin Pharm Ther 2011 36 5 602 613 10.1111/j.1365-2710.2010.01218.x 21143256
12. Outcomes of pharmacist-managed diabetes care service in a community health centre. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP, Am J Health Syst Pharm 2006 63 2116 2122 10.2146/ajhp060040 17057049 (Pubitemid 44757783)
13. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta analysis. Royal S, Smeaton L, Avery A, Hurwitz B, Sheik A, Qual Saf Health Care 2006 15 23 31 10.1136/qshc.2004.012153 16456206 (Pubitemid 43275522)
14. Implementation and evaluation of Australian pharmacists' diabetes care services. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I, J Am Pharm Assoc 2004 44 456 466
15. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S, Am J Manag Care 2005 11 253 260 15839185 (Pubitemid 40569748)
16. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Clifford RM, Batty KT, Davis TME, Davis W, Stein G, Stewart G, et al. Int J Pharm Pract 2002 10 85 89 10.1111/j.2042-7174.2002.tb00592.x (Pubitemid 34733343)
17. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Davidson MB, Karlan VJ, Hair TL, Am J Med Qual 2000 15 137 142 10.1177/106286060001500403 10948785
18. Retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Irons BK, Lenz RJ, Anderson SL, Wharton B, Habeger B, Anderson G, Pharmacotherapy 2002 22 1294 1300 10.1592/phco.22.15.1294.33476 12389879 (Pubitemid 35155082)
19. Evaluation of a pharmaceutical care model on diabetes management. Jaber L, Halapy H, Fernet M, Tummalapalli S, Diwakaran H, Ann Pharmacother 1996 30 238 243 8833557 (Pubitemid 126497295)
20. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Rothman RL, Malone R, Bryan B, Am J Med 2005 118 276 284 10.1016/j.amjmed.2004.09.017 15745726 (Pubitemid 40312639)
21. Auditing prescribing errors in a psychiatric hospital. Are pharmacists' interventions effective? Stubbs J, Haw C, Cahill C, Hosp Pharm 2004 11 203 206 (Pubitemid 38639422)
22. Altman DG, Practical Statistics for Medical Research United States: Chapman & Hall/CRC st edition 1999
23. The Joint Formulary Committee, British National Formulary (BNF) London: BMJ Group and Pharmaceutical Press rd edition 2012
24. MICROMEDEX® 1.0, Drug Interactions Thomson Reuters (Healthcare) Inc http://www.micromedex.com. (accessed February 20, 2010)
25. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. Lee JK, Grace KA, Taylor AJ, JAMA 2006 296 2563 2571 10.1001/jama.296.21.joc60162 17101639 (Pubitemid 44903860)
26. Effect of a multifactorial intervention on mortality in type 2 diabetes. Gæde P, Lund-Andersen H, Parving HH, Pedersen O, N Engl J Med 2008 358 580 591 10.1056/NEJMoa0706245 18256393 (Pubitemid 351214285)
27. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study (UKPDS) Group, BMJ 1998 317 703 713 10.1136/bmj.317.7160.703 9732337
28. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, et al. Arch Intern Med 2008 168 2355 2361 10.1001/archinte.168.21.2355 19029501
29. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Cohen LB, Taveira TH, Khatana SAM, Dooley AG, Pirraglia PA, Wu W-C, Diabetes Educ 2011 37 6 801 812 10.1177/0145721711423980 22021025